Sakashita T, Yanagitani N, Koike S, Low SK, et al. Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer. Cancer Sci 2022 Aug 11. doi: 10.1111/cas.15529.
PMID: 35950895